Poland · Delayed Price · Currency is PLN Nestmedic Statistics
Total Valuation
Nestmedic has a market cap or net worth of PLN 40.94 million. The enterprise value is 40.98 million.
| Market Cap | 40.94M |
| Enterprise Value | 40.98M |
Important Dates
The next confirmed earnings date is Wednesday, August 12, 2026.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Nestmedic has 55.33 million shares outstanding. The number of shares has increased by 49.57% in one year.
| Current Share Class | 55.33M |
| Shares Outstanding | 55.33M |
| Shares Change (YoY) | +49.57% |
| Shares Change (QoQ) | +16.82% |
| Owned by Insiders (%) | 9.48% |
| Owned by Institutions (%) | 2.89% |
| Float | 22.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 35.50 |
| PB Ratio | 4.30 |
| P/TBV Ratio | 4.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 35.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.60 |
| Quick Ratio | 1.05 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -22.50 |
Financial Efficiency
Return on equity (ROE) is -67.86% and return on invested capital (ROIC) is -28.54%.
| Return on Equity (ROE) | -67.86% |
| Return on Assets (ROA) | -18.90% |
| Return on Invested Capital (ROIC) | -28.54% |
| Return on Capital Employed (ROCE) | -42.07% |
| Weighted Average Cost of Capital (WACC) | 5.70% |
| Revenue Per Employee | 384,413 |
| Profits Per Employee | -1.45M |
| Employee Count | 3 |
| Asset Turnover | 0.09 |
| Inventory Turnover | 0.06 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +52.30% in the last 52 weeks. The beta is 0.23, so Nestmedic's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | +52.30% |
| 50-Day Moving Average | 0.64 |
| 200-Day Moving Average | 0.69 |
| Relative Strength Index (RSI) | 70.69 |
| Average Volume (20 Days) | 24,975 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Nestmedic had revenue of PLN 1.15 million and -4.35 million in losses. Loss per share was -0.10.
| Revenue | 1.15M |
| Gross Profit | 930,200 |
| Operating Income | -4.07M |
| Pretax Income | -4.35M |
| Net Income | -4.35M |
| EBITDA | -3.12M |
| EBIT | -4.07M |
| Loss Per Share | -0.10 |
Balance Sheet
The company has 1.21 million in cash and 1.25 million in debt, with a net cash position of -42,780 or -0.00 per share.
| Cash & Cash Equivalents | 1.21M |
| Total Debt | 1.25M |
| Net Cash | -42,780 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 9.52M |
| Book Value Per Share | 0.19 |
| Working Capital | 3.64M |
Cash Flow
| Operating Cash Flow | -8.19M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 942,620 |
| Net Borrowing | -225,000 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 80.66% |
| Operating Margin | -352.61% |
| Pretax Margin | -377.06% |
| Profit Margin | n/a |
| EBITDA Margin | -270.87% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Nestmedic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -49.57% |
| Shareholder Yield | -49.57% |
| Earnings Yield | -10.62% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Nestmedic has an Altman Z-Score of -0.16 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.16 |
| Piotroski F-Score | 3 |